DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo


0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

RCPT 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -7.14





News & Commentary Rss Feed

5 Things Celgene Corporation Wants You to Know

Celgene trounced Wall Street's expectations in the second quarter, but it's these five things that its management team most wants you to know.

Never Chase Stocks When They Are Up - Cramer's Mad Money (8/25/15)

Jim Cramer Advises His Viewers On Wells Fargo, Receptos And Celgene

Stocks Hitting 52-Week Highs

Stocks Hitting 52-Week Highs

Stocks Hitting 52-Week Highs

Unpartnered Assets Face Waiting Game

Celgene's Deal-Making Magic Lifts Receptos 20% in July

Receptos is being acquired by Celgene in a deal valued at more than $7 billion.

These 2 Catalysts Helped Push Celgene's Market Value Over $100 Billion in July

Celgene logs a 13% gain in July, and in the process joins an elite class of biotech stocks having crested the $100 billion value mark. Find out if Celgene's good fortune can continue.

What Next For M&A In Pharma And Biotech?

See More RCPT News...